Sensorion Announces CEO Transition and Interim Leadership Appointment
The Sensorion CEO transition marks a significant leadership update for Sensorion (FR0012596468 – ALSEN), a clinical-stage biotechnology company developing innovative therapies for hearing loss disorders. The company confirmed that...

